Fresenius Kabi recalls sodium acetate injection
Fresenius Kabi USA Monday recalledseven lots of sodium acetate injection after finding particulate matter in sample vials, which could cause infection or other serious adverse events if administered. No adverse events were reported. Hospitals should not use the recalled product, a sodium additive for intravenous fluids.
Related News Articles
Headline
In response to questions from AHA and others and informed by testing results, the Food and Drug Administration April 21 announced that health care…
Headline
The Food and Drug Administration today withdrew approval for Makena and its generics, citing a confirmatory study that did not verify clinical benefit.…
Headline
The U.S. Food & Drug Administration has issued a Class I recall, the most serious type of recall, for the Arrow MAC Two-Lumen Central Venous Access Kits…
Headline
Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, the Food and Drug Administration…
Headline
The Food and Drug Administration this week alerted health care providers to a shortage of tracheostomy tubes, used to help people breathe after a…
Headline
Exela Pharma Sciences this week recalled 49 lots of sodium bicarbonate injection because the vial may break while preparing the product for administration…